who's interested in vapendavir?

Thats the $64,000 question, 6 months after Vap's "data room" was opened up to Big Pharma.

Who indeed.

GSK is running a number of trials (either as sponsor or collaborator) looking at Mepolizumab to treat asthma exascerbations. One of the trials aims to use this monoclonal antibody at rhinovirus induced asthma exascerbations.

Rhinovirus Asthma Trial

This trial involves 3 infusions. I did a search of the cost of Mepolizumab but no luck. If its anything like Medimmune's RSV monoclonal antibody, it might be $2,000 per shot or $6,000 for the full course.

Synagis Cost

That's crazy money for people and insurers.

I don't know about Vap's cost, but I hazard a guess it would $100-200 for a full course?

Not to forget the inconvenience of IV vs oral.